Pim van der Harst

Author PubWeight™ 162.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 13.25
2 Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009 12.44
3 The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012 4.87
4 Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012 4.73
5 Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009 4.63
6 Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013 3.87
7 Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010 3.75
8 Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010 3.55
9 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013 3.25
10 New gene functions in megakaryopoiesis and platelet formation. Nature 2011 3.14
11 Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2012 3.04
12 Common variants near TERC are associated with mean telomere length. Nat Genet 2010 2.98
13 Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013 2.83
14 FTO genotype is associated with phenotypic variability of body mass index. Nature 2012 2.77
15 CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011 2.70
16 Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012 2.53
17 Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013 2.32
18 Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 2010 2.24
19 Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol 2013 2.18
20 Healthy aging and disease: role for telomere biology? Clin Sci (Lond) 2011 2.10
21 Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 2011 2.01
22 Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012 1.96
23 Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet 2013 1.72
24 Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 2010 1.68
25 Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 2012 1.67
26 The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord 2014 1.64
27 Biological ageing and cardiovascular disease. Heart 2008 1.64
28 Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 2007 1.62
29 Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Cardiovasc Drugs Ther 2008 1.57
30 Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 2013 1.54
31 Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr 2010 1.50
32 Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients. Hypertension 2006 1.49
33 Plasma renin and outcome in the community: data from PREVEND. Eur Heart J 2012 1.47
34 Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation. Int J Cardiol 2007 1.46
35 Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol 2014 1.45
36 Blood pressure loci identified with a gene-centric array. Am J Hum Genet 2011 1.44
37 Telomere biology in healthy aging and disease. Pflugers Arch 2009 1.41
38 Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects. J Renin Angiotensin Aldosterone Syst 2007 1.37
39 Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet 2013 1.27
40 Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood 2012 1.26
41 Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2011 1.26
42 Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol 2008 1.22
43 Genetic architecture of ambulatory blood pressure in the general population: insights from cardiovascular gene-centric array. Hypertension 2010 1.22
44 A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits. PLoS One 2013 1.20
45 Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation 2009 1.20
46 Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res 2013 1.10
47 Telomere length and psychological well-being in patients with chronic heart failure. Age Ageing 2010 1.04
48 Association between left ventricular mass and telomere length in a population study. Am J Epidemiol 2010 1.02
49 Aging, telomeres and heart failure. Heart Fail Rev 2010 1.02
50 Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy. Circ Cardiovasc Genet 2011 0.99
51 Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Cardiovasc Res 2008 0.99
52 Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail 2008 0.98
53 Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring. PLoS One 2011 0.97
54 Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 2010 0.97
55 GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia 2014 0.97
56 A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol. PLoS Genet 2011 0.97
57 Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2008 0.96
58 Circulating leukocyte and carotid atherosclerotic plaque telomere length: interrelation, association with plaque characteristics, and restenosis after endarterectomy. Arterioscler Thromb Vasc Biol 2011 0.95
59 Pathway analysis shows association between FGFBP1 and hypertension. J Am Soc Nephrol 2011 0.95
60 Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial. Cardiovasc Drugs Ther 2012 0.94
61 Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure. Heart 2011 0.94
62 Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system. Lab Invest 2010 0.94
63 Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Vascul Pharmacol 2005 0.90
64 A genome-wide association study of circulating galectin-3. PLoS One 2012 0.89
65 Sex differences in new-onset heart failure. Clin Res Cardiol 2014 0.89
66 The emerging role of telomere biology in cardiovascular disease. Front Biosci (Landmark Ed) 2010 0.89
67 Genome-wide meta-analysis of common variant differences between men and women. Hum Mol Genet 2012 0.88
68 Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo. Eur J Heart Fail 2010 0.88
69 Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality. J Am Heart Assoc 2012 0.87
70 Can critically short telomeres cause functional exhaustion of progenitor cells in postinfarction heart failure? J Am Coll Cardiol 2007 0.86
71 Pharmacoepigenetics in heart failure. Curr Heart Fail Rep 2010 0.86
72 Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1. Hypertension 2013 0.86
73 Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol 2009 0.85
74 Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure. Eur J Heart Fail 2010 0.85
75 Telomere biology in heart failure. Eur J Heart Fail 2008 0.85
76 Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol 2009 0.84
77 Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation. Mol Vis 2009 0.83
78 Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population. Heart 2012 0.83
79 Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction. Cardiovasc Drugs Ther 2014 0.81
80 Pharmacogenetics in heart failure: promises and challenges. Expert Opin Pharmacother 2009 0.80
81 Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system. Hypertension 2008 0.80
82 Dissecting the genetics of complex traits: lessons from hypertension. Nephrol Dial Transplant 2010 0.80
83 Reproducibility of Telomere Length Assessment - An International Collaborative Study. Int J Epidemiol 2015 0.80
84 Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004 0.80
85 Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis 2012 0.79
86 Expanding the concept of telomere dysfunction in cardiovascular disease. Arterioscler Thromb Vasc Biol 2008 0.79
87 Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes. Circ Cardiovasc Genet 2014 0.78
88 CCR5Delta32 genotype is associated with outcome in type 2 diabetes mellitus. Diabetes Res Clin Pract 2009 0.77
89 Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia 2014 0.77
90 Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2004 0.76
91 Statins and autonomic function in chronic heart failure. Cardiovasc Drugs Ther 2005 0.76
92 The association between intelligence and telomere length: a longitudinal population based study. PLoS One 2012 0.75
93 Online journals: paying or delaying? Lancet 2010 0.75
94 Letter by Huzen et al regarding article, "Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study". Circulation 2008 0.75
95 Aggressive lipid-lowering therapy and regression of coronary atheroma. JAMA 2004 0.75
96 Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial. Cardiovasc Drugs Ther 2015 0.75
97 Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA). Eur J Heart Fail 2015 0.75
98 HFpEF vs. HFrEF: can microRNAs advance the diagnosis? Eur J Heart Fail 2015 0.75
99 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
100 Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort. Eur J Epidemiol 2014 0.75
101 Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. Atherosclerosis 2006 0.75
102 The Nobel Prize for medicine for telomere biology and relevance to heart failure research. Eur J Heart Fail 2009 0.75
103 Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 2017 0.75
104 Refining Thromboembolic Risk in the General Population. J Am Coll Cardiol 2017 0.75
105 Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 2017 0.75
106 Genome-wide association reveals that common genetic variation in the kallikrein-kinin system is associated with serum L-arginine levels. Thromb Haemost 2016 0.75
107 Telomere Length and Risk of Cardiovascular Disease and Cancer. J Am Coll Cardiol 2017 0.75
108 Reply: Poor Sensitivity and Specificity of Electrocardiographic Estimation of Myocardial Mass. J Am Coll Cardiol 2017 0.75
109 Left ventricular ejection fraction and mortality in patients with ST-elevation myocardial infarction and bundle branch block. Coron Artery Dis 2016 0.75
110 Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun 2017 0.75
111 Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun 2015 0.75
112 New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals. Circ Cardiovasc Genet 2017 0.75
113 Genome-wide association studies identify genetic loci for low von Willebrand factor levels. Eur J Hum Genet 2016 0.75